Unlock Exclusive Discounts & Flash Sales! Click Here to Join the Deals on Every Wednesday!

Protein Identification by Peptide Mapping (CAT#: STEM-B-0010-ZJF)

Introduction

This service provides a method for peptide mapping of purified proteins using protease digestion and liquid chromatography tandem-mass spectrometry (LC-MS/MS).<br />Peptide mapping, an identity test for proteins, is an essential analytical method for elucidating the primary amino acid structure of proteins. For recombinant protein pharmaceuticals, such as monoclonal antibodies (mAbs) and antibody-drug conjugates (ADCs), peptide mapping is used for proof of identity, primary structural characterization, and quality assurance (QA). Regulatory agencies issued ICH Q6B guidance which specifies the use of peptide mapping as a critical quality test procedure for drug characterization used to confirm desired product structure for lot release purposes. Peptide mapping involves enzymatic treatment of a protein, resulting in the formation of peptide fragments, followed by separation and identification of the resultant fragments by LC-MS/MS in a reproducible manner. It can identify single amino acid changes resulting from events such as errors in the reading of complementary DNA (cDNA) sequences or point mutations.




Principle

Peptide mapping is a method for the identification of proteins, especially those obtained by rDNA technology. It involves chemical or enzymatic processing of proteins to form peptide fragments, which are then isolated and identified in a repeatable manner. This is a powerful test that is able to identify changes in almost any single amino acid that are caused by events such as a misread of a complementary DNA (cDNA) sequence or a point mutation. Peptide mapping is a comparison procedure because the information obtained confirms the primary structure of the protein, enables detection of whether the structure has changed, and demonstrates the consistency and genetic stability of the process when compared to reference substances of similar treatment. Each protein has unique characteristics that must be fully understood so that scientific and analytical methods allow the development of validated peptide maps that provide sufficient specificity.

Applications

Proteins, Biopharmaceutics

Procedure

1. Isolation and purification: This procedure is necessary for analysis of bulk drugs or dosage forms containing interfering excipients and carrier proteins.
2. Selective cleavage of peptide bonds: The method chosen for the cleavage of peptide bond depends on the protein being tested. This selection process involves determination of the type of cleavage to be employed, enzymatic or chemical, and the type of cleavage agent within the chosen category.
3. Chromatographic separation: Many techniques are used to separate peptides for mapping. The selection of a technique depends on the protein being mapped. Techniques used for the separation of
peptides: Reversed-phase high performance liquid chromatography (HPLC), Ion-exchange chromatography (IEC), Hydrophobic interaction chromatography (HIC), Polyacrylamide gel electrophoresis (PAGE), Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE), Capillary electrophoresis (CE), Paper chromatography-high voltage (PCHV), and High voltage-paper electrophoresis (HVPE).
4. Analysis and identification of peptides: The use of peptide maps as a qualitative tool does not require complete characterization of individual peptide peaks. Validation of peptide mapping in support of regulatory applications requires rigorous characterisation of each of the individual peaks in the peptide map.

Materials

• Chromatographic apparatus
• Mass spectrometry apparatus
• Sample material